Literature DB >> 19595904

Independent contributions of neural and "higher-order" deficits to symptoms in Alzheimer's disease: a latent variable modeling approach.

Rochelle E Tractenberg1, Paul S Aisen, Myron F Weiner, Jeffrey L Cummings, Gregory R Hancock.   

Abstract

BACKGROUND: Analytic models of Alzheimer's disease (AD) tend to focus on one type of symptom and assume implicitly that no measurement error is present. These tendencies render changes in symptom domains difficult to model mathematically, although latent variable methods can accommodate both multiple symptom domains and error. This study formulated and compared underlying (latent) factor structures representing previously reported dependence and independence of symptoms of cognitive decline, functional impairment, and behavioral disturbance in AD.
METHODS: In confirmatory factor analyses of data from 2 cohorts of AD patients, 2 levels of latent variables were conceptualized. One general neurologic factor represented disease, and symptom factors represented cognition, function, and behavior. Two "null" models had either a single factor or 3 symptom factors. Two 2-level models treated the general factor as underlying both the observed variables and the symptom factors or treated the symptom factors as explaining variability in the observed variables after taking the general factor into account ("residualized"). RESULTS/
CONCLUSIONS: The residualized model fit the data in both cohorts significantly better than the other models, and relations in this model between some observed and latent variables were different across cohorts. Neither cohort supported a single factor model; both cohorts independently supported a residualized model that may permit differentiation of symptom- from disease-modifying effects of treatment.

Entities:  

Year:  2006        PMID: 19595904      PMCID: PMC3118012          DOI: 10.1016/j.jalz.2006.08.001

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  27 in total

1.  A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

Authors:  P S Aisen; K L Davis; J D Berg; K Schafer; K Campbell; R G Thomas; M F Weiner; M R Farlow; M Sano; M Grundman; L J Thal
Journal:  Neurology       Date:  2000-02-08       Impact factor: 9.910

2.  Analysis of change: modeling individual growth.

Authors:  D J Francis; J M Fletcher; K K Stuebing; K C Davidson; N M Thompson
Journal:  J Consult Clin Psychol       Date:  1991-02

3.  On the importance of longitudinal research in Alzheimer's disease.

Authors:  J A Yesavage; J O Brooks
Journal:  J Am Geriatr Soc       Date:  1991-09       Impact factor: 5.562

4.  An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Authors:  D Galasko; D Bennett; M Sano; C Ernesto; R Thomas; M Grundman; S Ferris
Journal:  Alzheimer Dis Assoc Disord       Date:  1997       Impact factor: 2.703

5.  Temporal quantification of Alzheimer's disease severity: 'time index' model.

Authors:  J W Ashford; M Shan; S Butler; A Rajasekar; F A Schmitt
Journal:  Dementia       Date:  1995 Sep-Oct

6.  The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy.

Authors:  R C Mohs; W G Rosen; K L Davis
Journal:  Psychopharmacol Bull       Date:  1983

7.  Assessing patient dependence in Alzheimer's disease.

Authors:  Y Stern; S M Albert; M Sano; M Richards; L Miller; M Folstein; M Albert; F W Bylsma; G Lafleche
Journal:  J Gerontol       Date:  1994-09

8.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

Authors:  S T DeKosky; S W Scheff
Journal:  Ann Neurol       Date:  1990-05       Impact factor: 10.422

9.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

10.  Emergent psychopathology in Alzheimer's disease patients over 12 months associated with functional, not cognitive, changes.

Authors:  Rochelle E Tractenberg; Myron F Weiner; Marian B Patterson; Anthony Gamst; Leon J Thal
Journal:  J Geriatr Psychiatry Neurol       Date:  2002       Impact factor: 2.680

View more
  9 in total

1.  Analytic methods for factors, dimensions and endpoints in clinical trials for Alzheimer's disease.

Authors:  R E Tractenberg
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

2.  Social cognition in Alzheimer's disease: a separate construct contributing to dependence.

Authors:  Stephanie Cosentino; Laura B Zahodne; Jason Brandt; Deborah Blacker; Marilyn Albert; Bruno Dubois; Yaakov Stern
Journal:  Alzheimers Dement       Date:  2014-03-18       Impact factor: 21.566

3.  Agreement in cognitive and clinical assessments in Alzheimer's disease.

Authors:  Rochelle E Tractenberg; Paul S Aisen
Journal:  Dement Geriatr Cogn Disord       Date:  2009-03-17       Impact factor: 2.959

4.  Examination of the Factor Structure of a Global Cognitive Function Battery across Race and Time.

Authors:  Lisa L Barnes; Futoshi Yumoto; Ana Capuano; Robert S Wilson; David A Bennett; Rochelle E Tractenberg
Journal:  J Int Neuropsychol Soc       Date:  2015-11-13       Impact factor: 2.892

5.  No cross-sectional influence of APOE epsilon4 dose on clinical tests in Alzheimer's disease.

Authors:  Rochelle E Tractenberg; Paul S Aisen; Gregory R Hancock; G William Rebeck
Journal:  Neurobiol Aging       Date:  2008-02-20       Impact factor: 4.673

6.  Predicting the progression of Alzheimer's disease dementia: A multidomain health policy model.

Authors:  Colin Green; Shenqiu Zhang
Journal:  Alzheimers Dement       Date:  2016-03-24       Impact factor: 21.566

7.  Personalized predictive modeling for patients with Alzheimer's disease using an extension of Sullivan's life table model.

Authors:  Eric Stallard; Bruce Kinosian; Yaakov Stern
Journal:  Alzheimers Res Ther       Date:  2017-09-20       Impact factor: 6.982

8.  A comparison of two approaches for modeling dementia progression in a changing patient context.

Authors:  Nina Wubben; Miriam Haaksma; Inez H G B Ramakers; Wiesje M van der Flier; Frans R J Verhey; Marcel G M Olde Rikkert; René J F Melis
Journal:  Int J Geriatr Psychiatry       Date:  2022-05       Impact factor: 3.850

9.  Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes.

Authors:  Miriam L Haaksma; Amaia Calderón-Larrañaga; Marcel G M Olde Rikkert; René J F Melis; Jeannie-Marie S Leoutsakos
Journal:  Int J Geriatr Psychiatry       Date:  2018-05-15       Impact factor: 3.485

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.